Posted by Michael Wonder on 10 Sep 2019
Frontrunner to lead FDA, dogged by controversies, has developed knack for confronting them
10 September 2019 - Before he interviewed with President Trump last week to become FDA commissioner, Dr. Stephen Hahn had only been here once in a formal capacity: to apologise to Congress.
The veteran cancer researcher came to Capitol Hill in 2009 to take responsibility for years of botched care by a doctor under his supervision. Ninety-two U.S. military veterans had been implanted with radioactive “seeds,” meant to fight prostate cancer, at the wrong dose — or in the wrong organ entirely.
It was the first of multiple controversies that have dogged Hahn, who worked then as the chair of radiation oncology at the University of Pennsylvania School of Medicine, throughout his career.
